ICUI Stock Overview
Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
ICU Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$152.71 |
| 52 Week High | US$153.55 |
| 52 Week Low | US$78.28 |
| Beta | 0.70 |
| 11 Month Change | 24.15% |
| 3 Month Change | 42.59% |
| 1 Year Change | 7.23% |
| 33 Year Change | -18.71% |
| 5 Year Change | -8.00% |
| Change since IPO | 3,211.78% |
Recent News & Updates
Recent updates
ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly
Aug 07
ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult
Jun 27ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price
Jun 23Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package
May 09Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S
Apr 26ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Mar 31Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?
Jan 31ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business
Jan 04These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively
Oct 28Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?
Oct 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jul 19Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Jun 22Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt
Apr 03Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 27ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Dec 07ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Sep 07ICU Medical Hit Hard As Smiths Medical Needs Significant TLC
Aug 20ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M
Aug 08FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious
Jul 20ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt
Jun 08ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value
Mar 25A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Feb 23Analysts Just Made A Significant Upgrade To Their ICU Medical, Inc. (NASDAQ:ICUI) Forecasts
Jan 28Is Now The Time To Put ICU Medical (NASDAQ:ICUI) On Your Watchlist?
Dec 05A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Nov 04Shareholder Returns
| ICUI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 21.3% | 0.3% | -2.3% |
| 1Y | 7.2% | 4.4% | 16.7% |
Return vs Industry: ICUI exceeded the US Medical Equipment industry which returned 4.4% over the past year.
Return vs Market: ICUI underperformed the US Market which returned 16.7% over the past year.
Price Volatility
| ICUI volatility | |
|---|---|
| ICUI Average Weekly Movement | 8.6% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: ICUI's share price has been volatile over the past 3 months.
Volatility Over Time: ICUI's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 14,000 | Vivek Jain | www.icumed.com |
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
ICU Medical, Inc. Fundamentals Summary
| ICUI fundamental statistics | |
|---|---|
| Market cap | US$3.70b |
| Earnings (TTM) | -US$70.79m |
| Revenue (TTM) | US$2.30b |
1.6x
P/S Ratio-52.7x
P/E RatioIs ICUI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICUI income statement (TTM) | |
|---|---|
| Revenue | US$2.30b |
| Cost of Revenue | US$1.56b |
| Gross Profit | US$748.18m |
| Other Expenses | US$818.96m |
| Earnings | -US$70.79m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.90 |
| Gross Margin | 32.47% |
| Net Profit Margin | -3.07% |
| Debt/Equity Ratio | 78.8% |
How did ICUI perform over the long term?
See historical performance and comparison